Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Véronique Abitbol"'
Autor:
Véronique Abitbol, Federico Martinón-Torres, Muhamed-Kheir Taha, Terry Nolan, Alessandro Muzzi, Stefania Bambini, Ray Borrow, Daniela Toneatto, Laura Serino, Rino Rappuoli, Mariagrazia Pizza
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
The 4-component meningococcal serogroup B (MenB) vaccine, 4CMenB, the first broadly protective, protein-based MenB vaccine to be licensed, is now registered in more than 50 countries worldwide. Real-world evidence (RWE) from the last decade confirms
Externí odkaz:
https://doaj.org/article/380746a45f9448248f21e680320ecf7a
Autor:
Ray Borrow, Federico Martinón-Torres, Véronique Abitbol, Anar Andani, Scott Preiss, Alessandro Muzzi, Laura Serino, Woo-Yun Sohn
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 738-748 (2023)
Introduction Neisseria meningitidis serogroup B (NmB) antigens are inherently diverse with variable expression among strains. Prediction of meningococcal B (MenB) vaccine effectiveness therefore requires an assay suitable for use against large panels
Externí odkaz:
https://doaj.org/article/4e1c2a33874d4f68b50c1a9a666b28e7
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
The four-component meningococcal serogroup B vaccine (4CMenB) is indicated for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup B. Co-administering 4CMenB with other vaccines may improve vaccine uptake
Externí odkaz:
https://doaj.org/article/c7afad51c3a540f58b240dfedee8639d
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Invasive meningococcal disease (IMD) is a life-threatening disease caused by Neisseria meningitidis and has high mortality rates. Survivors often exhibit long-term sequelae and reduced life expectancy. Disease incidence is highest in infants and todd
Externí odkaz:
https://doaj.org/article/508f76067ab740b8b181d5f7404edcb8
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 2, Pp 470-480 (2019)
Invasive meningococcal disease (IMD) is a serious disease that is fatal in 5–15% and disabling in 12–20% of cases. The dynamic and unpredictable epidemiology is a particular challenge of IMD prevention. Although vaccination against meningococcal
Externí odkaz:
https://doaj.org/article/2f341ed581224b88bc57a043d00ba3bc
Autor:
Nicole Guiso, France de La Rocque, Elisabeth Njamkepo, Aurelie Lécuyer, Corinne Levy, Olivier Romain, Franck Thollot, Véronique Abitbol, Benoit Soubeyrand, Robert Cohen
Publikováno v:
Emerging Infectious Diseases, Vol 14, Iss 7, Pp 1159-1161 (2008)
Externí odkaz:
https://doaj.org/article/6b22f81e98a14b57a918b02a79b0231a
Autor:
Yara Ruiz Garcia, Véronique Abitbol, Michele Pellegrini, Rafik Bekkat-Berkani, Lamine Soumahoro
Publikováno v:
Infectious Diseases and Therapy. 11:657-659
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69f31536dab92515a577074e2dc0bef9
https://doi.org/10.1007/s40121-021-00554-z
https://doi.org/10.1007/s40121-021-00554-z
Autor:
Muhamed-Kheir Taha, Federico Martinon-Torres, Ralph Köllges, Paolo Bonanni, Marco Aurelio Palazzi Safadi, Robert Booy, Vinny Smith, Stéphanie Garcia, Rafik Bekkat-Berkani, Véronique Abitbol
Publikováno v:
Expert review of vaccines. 21(5)
Social deprivation is associated with poorer healthcare access. Vaccination is among the most effective public health interventions and achieving equity in vaccination access is vitally important. However, vaccines are often reimbursed by public fund
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bec49fa104f747f29b22d1d08491bb4
https://pubmed.ncbi.nlm.nih.gov/35271781
https://pubmed.ncbi.nlm.nih.gov/35271781
Autor:
Federico Martinón-Torres, Michele Pellegrini, Véronique Abitbol, Muhamed-Kheir Taha, Victoria Abbing-Karahagopian, Rafik Bekkat-Berkani, Markus Knuf
Invasive meningococcal disease (IMD) is a life-threatening, unpredictable condition. Vaccines are available against 5 of the 6 meningococcal serogroups (Men) accounting for nearly all IMD cases worldwide; conjugate monovalent MenC, quadrivalent MenAC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754c613a1d33f3a813fb26f06521a496
Autor:
Yara Ruiz Garcia, Véronique Abitbol, Rafik Bekkat-Berkani, Michele Pellegrini, Lamine Soumahoro
Publikováno v:
Infectious Diseases and Therapy
The quadrivalent A, C, W and Y meningococcal vaccine conjugated to nontoxic mutant of diphtheria toxin (MenACWY-CRM) has been licensed since 2010 for the prevention of invasive meningococcal disease (IMD), an uncommon but life-threatening condition.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf20e8653b782be92a846f30f275d397
https://pubmed.ncbi.nlm.nih.gov/34837646
https://pubmed.ncbi.nlm.nih.gov/34837646